chrX-54446376-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_004463.3(FGD1):c.2619C>T(p.Phe873Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000141 in 1,209,196 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000010 ( 0 hom. 6 hem. )
Consequence
FGD1
NM_004463.3 synonymous
NM_004463.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.470
Genes affected
FGD1 (HGNC:3663): (FYVE, RhoGEF and PH domain containing 1) This gene encodes a protein that contains Dbl (DH) and pleckstrin (PH) homology domains and is similar to the Rho family of small GTP-binding proteins. The encoded protein specifically binds to the Rho family GTPase Cdc42Hs and can stimulate the GDP-GTP exchange of the isoprenylated form of Cdc42Hs. It also stimulates the mitogen activated protein kinase cascade leading to c-Jun kinase SAPK/JNK1 activation. Defects in this gene are the cause of the faciogenital dysplasia in Aarskog-Scott syndrome and a syndromatic form of X-linked cognitive disability. [provided by RefSeq, Jul 2017]
TSR2 (HGNC:25455): (TSR2 ribosome maturation factor) The protein encoded by this gene appears to repress the transcription of NF-kappaB and may be involved in apoptosis. Defects in this gene are a cause of Diamond-Blackfan anemia. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant X-54446376-G-A is Benign according to our data. Variant chrX-54446376-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 585860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.47 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0000534 (6/112315) while in subpopulation AFR AF= 0.000194 (6/30923). AF 95% confidence interval is 0.0000844. There are 0 homozygotes in gnomad4. There are 1 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAdExome4 at 6 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGD1 | NM_004463.3 | c.2619C>T | p.Phe873Phe | synonymous_variant | 18/18 | ENST00000375135.4 | NP_004454.2 | |
TSR2 | NM_058163.3 | c.*1826G>A | 3_prime_UTR_variant | 5/5 | ENST00000375151.5 | NP_477511.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGD1 | ENST00000375135.4 | c.2619C>T | p.Phe873Phe | synonymous_variant | 18/18 | 1 | NM_004463.3 | ENSP00000364277.3 | ||
TSR2 | ENST00000375151.5 | c.*1826G>A | 3_prime_UTR_variant | 5/5 | 1 | NM_058163.3 | ENSP00000364293.4 |
Frequencies
GnomAD3 genomes AF: 0.0000534 AC: 6AN: 112315Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34501
GnomAD3 genomes
AF:
AC:
6
AN:
112315
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34501
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000337 AC: 6AN: 177843Hom.: 0 AF XY: 0.0000632 AC XY: 4AN XY: 63251
GnomAD3 exomes
AF:
AC:
6
AN:
177843
Hom.:
AF XY:
AC XY:
4
AN XY:
63251
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000100 AC: 11AN: 1096881Hom.: 0 Cov.: 31 AF XY: 0.0000166 AC XY: 6AN XY: 362335
GnomAD4 exome
AF:
AC:
11
AN:
1096881
Hom.:
Cov.:
31
AF XY:
AC XY:
6
AN XY:
362335
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000534 AC: 6AN: 112315Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34501
GnomAD4 genome
AF:
AC:
6
AN:
112315
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34501
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 18, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 27, 2018 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at